LTA.sub.4 , hydrolase inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514422, 514423, 514427, 514428, 514429, 546213, 548518, 548531, 548537, 548561, 548565, C07D20708, C07D207325, A61K 3140

Patent

active

059256540

ABSTRACT:
The present invention provides compounds having the structure: ##STR1## and pharmaceutically acceptable salts and stereoisomers thereof that are useful in the treatment of inflammatory diseases which are mediated by LTB.sub.4 production, such as psoriasis, ulcerative colitis, IBD, and asthma.

REFERENCES:
patent: 5700816 (1997-12-01), Isakson et al.
Chem. Abstracts, vol. 117(11), Abstr. No. 111411, Sep. 14, 1992.
Yuan et al., Chem. Abstracts, vol. 126(1), Abstr. No. 302, Jan.1, 1997.
Cavallini et al., Chem. Abstracts, vol. 53(10), Abstr. No. 9194, May 25, 1959.
Labaudiniere, R. et al., J. Med. Chem., vol. 35 (17), pp. 3156-3169 (1992).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

LTA.sub.4 , hydrolase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with LTA.sub.4 , hydrolase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and LTA.sub.4 , hydrolase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1322160

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.